Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in

  News Archive

Cell Surface Discovery May Lead to Major Breakthrough in Cancer Treatment
Friday, September 11, 2015
University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease.

TxCell Announces Publication of Preclinical Efficacy Results for Col-Treg
Thursday, September 10, 2015
Results published in Investigative Ophthalmology and Visual Science (IOVS) provide details on the demonstration of Col-Treg’s therapeutic potential in autoimmune uveitis and will support its ongoing clinical development.

The Achilles' Heel of HIV
Thursday, September 10, 2015
Researchers at the University of Bonn show how our body detects viruses and how HIV tries to mask itself.

Big Data Tool to Reveal Immune System Role in Diseases
Thursday, September 10, 2015
Researchers from the Icahn School of Medicine at Mount Sinai and Princeton University have designed a new online tool that predicts the role of key proteins and genes in diseases of the human immune system.

Viral Product That Promotes Immune Defense Against RSV Identified
Wednesday, September 09, 2015
A new study has identified a subset of viral products that are responsible for eliciting a strong immune response against RSV in people who become infected.

Study Creates Cell Immunity to Parasite that Infects 50 Million
Wednesday, September 09, 2015
A new paper demonstrates the effectiveness of a novel strategy for protecting humans from infectious disease : Adjusting the landscape of the human body to remove the mechanism that allows pathogens to cause disease.

Horizon, Abcam Sign License and Supply Agreement
Wednesday, September 09, 2015
Horizon Discovery Group plc and Abcam plc have announced the formation of a license and supply agreement between the two companies.

Cause of Rare Genetic Bone Disease Described
Tuesday, September 08, 2015
Regeneron Pharmaceuticals have announced a paper describing the discovery and preclinical validation of a key biologic mechanism that drives the pathophysiology of the rare genetic disorder Fibrodysplasia Ossificans Progressiva (FOP).

Aspirin Could Hold the Key to Supercharged Cancer Immunotherapy
Monday, September 07, 2015
Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to new research.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 1600

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos